Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Adaptimmune, after bringing cell therapy to market, questions viability and cuts 2 preclinical
Fierce Biotech
Thursday, March 20, 2025 - 9:57pm
tags:
Adaptimmune Therapeutics, cell therapy, afami-cel, Tecelra, solid tumors
Why Prime Medicine Stock Was Climbing Higher This Week
Motley Fool
Thursday, March 20, 2025 - 9:51pm
tags:
Prime Medicine, alpha-1 antitrypsin deficiency, gene editing
Neurocrine Biosciences debuts new data for effectiveness of Ingrezza
Clinical Trials Arena
Thursday, March 20, 2025 - 9:50pm
tags:
Neurocrine Biosciences, clinical trials, Ingrezza
Sanofi to acquire Dren Bio’s immunology unit
Investing.com
Thursday, March 20, 2025 - 11:25am
tags:
Sanofi, Dren Bio, immunology, DR-0201, M&A, autoimmune diseases
Paratek broadens portfolio with Optinose buy worth up to $330m
BioSpace
Thursday, March 20, 2025 - 11:23am
tags:
Paratek, OptiNose, chronic rhinosinusitis, M&A
'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up
Fierce Biotech
Thursday, March 20, 2025 - 11:17am
tags:
Novo Nordisk, R&D, layoffs
Patients scramble as cheaper obesity drug alternatives disappear
NPR
Thursday, March 20, 2025 - 11:15am
tags:
patients, tirzepatide, weight loss, compounding pharmacies, Zepbound
BioNTech passes on Autolus’ CD19/CD22 CAR-T amid pipeline prioritization
Fierce Biotech
Thursday, March 20, 2025 - 11:13am
tags:
BioNTech, Autolus Therapeutics, CAR-T, cell therapy
Funding drought: how can biotech and biopharma keep trials running?
Clinical Trials Arena
Thursday, March 20, 2025 - 11:12am
tags:
funding, biotech, clinical trials
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune
Fierce Biotech
Thursday, March 20, 2025 - 11:11am
tags:
Century Therapeutics, cell therapy, cancer, autoimmune diseases
Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial
MSN/Reuters
Thursday, March 20, 2025 - 10:18am
tags:
Eli Lilly, Mounjaro, India, weight loss, Novo Nordisk
AstraZeneca takes to the pickleball court for Fasenra campaign
Medical Marketing and Media
Thursday, March 20, 2025 - 10:06am
tags:
AstraZeneca, Fasenra, DTC advertising, sponsorship
The key factors shaping China’s biopharma boom
Pharma Voice
Thursday, March 20, 2025 - 9:57am
tags:
China, biotech, tariffs, regulatory, CAR-T
Roche's gantenerumab 'shows sign of preventing Alzheimer's dementia'
Pharmaphorum
Thursday, March 20, 2025 - 9:56am
tags:
Roche, gantenerumab, clinical trials, Alzheimer's disease
Some FDA staff considering quitting due to Trump’s RTO policy
RAPS.org
Wednesday, March 19, 2025 - 11:15pm
tags:
FDA, Donald Trump, remote work
Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims
Fierce Pharma
Wednesday, March 19, 2025 - 11:13pm
tags:
Purdue Pharma, bankruptcy, legal, opioids, opioid crisis
REGENXBIO reports promising gene therapy trial results
Investing.com
Wednesday, March 19, 2025 - 11:12pm
tags:
Regenxbio, DMD, RGX-202
Immunovant claims study success for immune disease drug but holds off on submission
BioPharma Dive
Wednesday, March 19, 2025 - 11:10pm
tags:
Immunovant, autoimmune disease, batoclimab
Alnylam’s Amvuttra Expected to Make Three in Crowded ATTR-CM Space
BioSpace
Wednesday, March 19, 2025 - 11:08pm
tags:
Alnylam, ATTR-CM, Pfizer, Bridge Bio, vutrisiran
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
Fierce Pharma
Wednesday, March 19, 2025 - 11:47am
tags:
Pfizer, Haleon, consumer health

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.